Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lauren Bjork
Observed name:
Lauren L. Bjork
Observed institutions:
The University of Texas at San Antonio Health Science Center,
Kingsbrook Jewish Medical Center,
Bruce W. Carter VA Medical Center,
South Texas Veterans Health Care System,
Miami VA Healthcare System,
The University of Texas at Austin
show all 6
OpenAlex ID:
A5045906274
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022
·
ACTIV-3/TICO Study Group*
, Christina Barkauskas
, et al.
·
Annals of Internal Medicine
·
31
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024
·
Neil R Aggarwal
, Jacquie Nordwall
, et al.
·
Clinical Infectious Diseases
·
15
PDF
Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
2023
·
Lauren Bjork
, Teri Hopkins
, et al.
·
International Journal of Medical Sciences
·
11
PDF
Proactive risk stratification and low-risk penicillin allergy delabeling by an antimicrobial stewardship pharmacist
2024
·
Breana N. Caturano
, Lauren L. Bjork
, et al.
·
Antimicrobial Stewardship & Healthcare Epidemiology
·
6
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023
·
Tomas O Jensen
, Greg A Grandits
, et al.
·
The Journal of Infectious Diseases
·
4
PDF
118. Feasibility of a Proactive Amoxicillin Oral Challenge Program for Inpatients with Penicillin Allergy at the Miami VAMC
2021
·
Michael J Piazza
, Paola Lichtenberger
, et al.
·
Open Forum Infectious Diseases
·
4
Timely explantation of tobramycin-impregnated beads and bone cement to avoid haemodialysis in a patient with worsening renal failure
2022
·
Joseph Jeffry Borick
, Shuba Balan
, et al.
·
BMJ Case Reports
·
3
1177. Clinical Pharmacist-Lead Amoxicillin Oral Challenges in Low-Risk Penicillin Allergy Patients
2023
·
Breana Caturano
, Lauren Bjork
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
110. MRSA nasal swab as a stewardship tool to guide IV Vancomycin in diabetic foot infections
2021
·
Alex Lazo-Vasquez
, Michael Piazza
, et al.
·
Open Forum Infectious Diseases
·
1
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019
2020
·
Stephen R Morris
, Yoichiro Natori
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
1795. Safety Outcomes of the Use of β-Lactam Therapy in Patients With Documented β-Lactam Allergy
2018
·
Lauren Bjork
·
Open Forum Infectious Diseases
·
1
PDF
P-1170. Impact of Increased Severity of Illness on Outcomes in Complicated Urinary Tract Infections (cUTI) from ZEUS, a Randomized Controlled Trial (RCT) Evaluating IV Fosfomycin (IV-FOS)
2026
·
Andrew Shorr
, Keith S Kaye
, et al.
·
Open Forum Infectious Diseases
1775. Interns and Residents’ Knowledge and Perspective on Appropriate Use of Antibiotics for Urinary Tract Infections and Skin and Soft Tissue Infections in the Hospital Setting
2022
·
Gabriel Motoa
, Joseph Borick
, et al.
·
Open Forum Infectious Diseases
165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
2019
·
Lauren Bjork
, Teri Hopkins
, et al.
·
Open Forum Infectious Diseases
Safety Outcomes of the Use of Beta-Lactam Therapy in Patients with Documented Beta-Lactam Allergy
2018
·
Lauren Bjork
·
IDWeek 2018
Show more works
View as search
Works count:
15
Citation count:
78
H-index:
4
I10-index:
3
Year
Topic
Type
